112 related articles for article (PubMed ID: 7438330)
1. The pharmacologic fate of the antitumor agent 2-amino-1,3,4-thiadiazole in the dog.
Lu K; Loo TL
Cancer Chemother Pharmacol; 1980; 4(4):275-9. PubMed ID: 7438330
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2 [(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride in the dog.
Lu K; Savaraj N; Loo TL
Cancer Chemother Pharmacol; 1984; 13(1):63-6. PubMed ID: 6733844
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of thiopurines III. beta-2'-Deoxythioguanosine and 6-thioguanine in the dog.
Loo TL; Lu K; Benvenuto JA; Rosenblum MG
Cancer Chemother Pharmacol; 1981; 6(2):131-6. PubMed ID: 7307231
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Amonafide in dogs.
Lu K; McLean MA; Vestal ML; Newman RA
Cancer Chemother Pharmacol; 1988; 21(2):134-8. PubMed ID: 3349561
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of homoharringtonine in dogs.
Lu K; Savaraj N; Feun LG; Guo ZG; Umsawasdi T; Loo TL
Cancer Chemother Pharmacol; 1988; 21(2):139-42. PubMed ID: 3349562
[TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of the antitumor agent pyrazine-2-diazohydroxide in mouse and beagle dog.
Moore DJ; Brodfuehrer JI; Wilke TJ; Powis G
Cancer Chemother Pharmacol; 1988; 21(4):269-73. PubMed ID: 3370734
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
Stüben J; Port R; Bertram B; Bollow U; Hull WE; Schaper M; Pohl J; Wiessler M
Cancer Chemother Pharmacol; 1996; 38(4):355-65. PubMed ID: 8674159
[TBL] [Abstract][Full Text] [Related]
8. Metabolic fate of diltiazem. Distribution, excretion and protein binding in rat and dog.
Nakamura S; Suzuki T; Sugawara Y; Usuki S; Ito Y; Kume T; Yoshikawa M; Endo H; Ohashi M; Harigaya S
Arzneimittelforschung; 1987 Nov; 37(11):1244-52. PubMed ID: 3440032
[TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
11. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
[TBL] [Abstract][Full Text] [Related]
12. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
14. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey.
Kanai Y; Nakai Y; Nakajima N; Tanayama S
Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449
[TBL] [Abstract][Full Text] [Related]
15. The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles.
Feun LG; Savaraj N; Lu K; Guo Z; Raulston LG; Benjamin RS; Fields WS; Loo TL
J Neurooncol; 1983; 1(3):219-24. PubMed ID: 6678971
[TBL] [Abstract][Full Text] [Related]
16. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of glucosamine in the dog and in man.
Setnikar I; Giacchetti C; Zanolo G
Arzneimittelforschung; 1986 Apr; 36(4):729-35. PubMed ID: 3718596
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
20. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
